Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
04/2003
04/30/2003CN1414944A Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1413642A Method for extracting chrysanthemum medicinal component and extract
04/30/2003CN1107110C Supercritical carbon dioxide extraction process of proto-oyanidin oligomer from grape seed
04/30/2003CN1107065C Method of extracting isoflavone, saponin, oligosauharide and protein simultaneously from defatted soybean dregs
04/30/2003CN1106840C Naringin and naringenin as 3-hydroxyl-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
04/29/2003US6555580 Treating arteriosclerosis and hypercholesterolaemia
04/29/2003US6555575 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease
04/29/2003US6555574 Antiarrhythmic agents
04/29/2003US6555571 3-methyl -chromane or thiochromane derivatives
04/29/2003US6555523 Use of cirsiliol and derivatives to treat infections
04/29/2003US6555332 Calibration using fluorescence signals
04/29/2003US6555028 Polymeric matrix compatibilized naphthopyrans
04/29/2003US6554965 Rectification column for isolating pure substances from high boiling air-and/or temperature sensitive substances
04/24/2003WO2003033467A1 Nitroso diphenylamine derivatives as nitrogen monoxide generating agents
04/24/2003US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients
04/24/2003US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/24/2003US20030078258 Adrenergic blocking agents
04/24/2003US20030078249 VLA-4 inhibitor compounds
04/24/2003US20030077760 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
04/24/2003US20030077707 Adjusting transferase domain in modular polyketide synthase; obtain nucleotide sequences, adjust sequences, express sequences, monitor activity of synthase
04/24/2003US20030077635 Dendrimer for use as diagnostic tools in chemical analysis
04/23/2003EP1303505A1 Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003EP1303187A2 Process for obtaining solid soy isoflavone-containing products
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1254131A4 Extraction of flavonoids
04/23/2003EP1222183B1 Benzopyran derivatives
04/23/2003EP0946440B1 2-adamantyl benzopyrans, the compositions and (co)polymer matrices containing them
04/23/2003EP0915846B1 2- and 2,5-substituted phenylketoenols
04/23/2003CN1413117A Drugs, drinks or foods
04/23/2003CN1412163A Preparation method of total saponin and flavone extract in notoginseng leaf
04/23/2003CN1411811A 血液循环改善剂 Blood circulation improving agent
04/23/2003CN1106394C Dihydrobenzopyran and dihydrobenzopyran compound and their use
04/22/2003US6552069 3-methyl-chroman and -thiochroman derivatives
04/22/2003US6552068 Having anti-estrogenic activity; for use in therapy
04/22/2003US6552054 Chromone derivatives, process for the preparation of the same and uses thereof
04/22/2003CA2022436C 7-hydroxy coumarins having substitutions in the 4 position
04/17/2003WO2003031430A2 Flavonoid compounds and their pharmaceutical uses
04/17/2003WO2003031429A1 A process for the stereoselective synthesis of 2-hydroxymethyl-chromans
04/17/2003WO2003031428A1 Stereospecific process for the synthesis of 2-yl chroman derivatives
04/17/2003WO2003020259A3 Combinations of dmxaa and other anti-cancer agents
04/17/2003WO2002058694A9 Method of treating hematologic tumors and cancers using beta lapachone
04/17/2003US20030073844 Process for the preparation of chiral glucocorticoid receptor agents
04/17/2003US20030073841 New benzo [b] pyrano [3,2-h] acridin-7-one compounds
04/17/2003US20030073839 Compounds useful for preparation of Beta-3 adrenoreceptor agonist
04/17/2003US20030073735 Novel 7,8-dihydro-xanthenone-8-carboxylic acid derivative and novel microbe producing the same
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030071268 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
04/17/2003US20030071247 Novel indeno-fused photochromic naphthopyrans
04/17/2003CA2462860A1 Stereospecific process for the synthesis of 2-yl chroman derivatives
04/17/2003CA2462809A1 Flavonoid compounds and their pharmaceutical uses
04/17/2003CA2462156A1 A process for the stereoselective synthesis of 2-hydroxymethyl-chromans
04/16/2003EP1302470A1 Lipid-rich plaque inhibitors
04/16/2003EP1302203A1 Stem cell reinforcing material
04/16/2003EP1301504A1 Bifunctional agents possessing antioxidant and antiarrhythmic activity
04/16/2003EP1301503A1 Coumarin derivatives with comt inhibiting activity
04/16/2003EP1301493A2 Heterocycle carboxamides as antiviral agents
04/16/2003EP1153021B1 Naphthopyrans and phenanthropyrans annelated in c5-c6 with a bicyclic group, and compositions and (co)polymer matrices containing them
04/16/2003EP1067127B1 Novel beta-diketone compounds, beta-diketone compounds coordinated to metal, method of organic synthesis with these, and catalyst
04/16/2003EP1015442B1 Process for preparing 3-isochromanone
04/16/2003EP0765160B1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
04/16/2003CN1411447A Polymorphic crystalline forms of celecoxib
04/16/2003CN1410424A Extraction technology of new stellerin A
04/16/2003CN1410423A Technical method of extracting rutin
04/16/2003CN1105714C Process for mfg. d, 1-alpha-tocopherol
04/15/2003US6548695 Process for producing isocoumarins and intermediates for the same
04/15/2003US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
04/15/2003US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms
04/15/2003US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives
04/10/2003WO2003029239A1 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003WO2003029237A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
04/10/2003WO2003029198A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
04/10/2003WO2003028652A2 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
04/10/2003WO2003004486A3 Process for preparing isocoumarins
04/10/2003WO2001087295A8 Methods for decreasing cell proliferation based on (3r, 4r)-δ8-tetrahydrocannabinol-11-oic acids
04/10/2003US20030069396 Neutralizing agent for toxin of microorganism belonging to the genus clostridium
04/10/2003US20030069303 Osteoporosis, postmenopause
04/10/2003US20030069224 Non-nucleoside reverse transcriptase inhibitors
04/10/2003US20030069192 May be administered along with Rutin, a Rutin congener and/or a Rutin derivative.
04/10/2003US20030069168 Especially flavanoids or chromones containing a rhamnose group that have selective inhibitory activity against the activated T cells
04/10/2003US20030068677 Recombinant production of novel polyketides
04/10/2003US20030068668 Compound for use as diagnostic tool in the determination of hydrogen ion concentration in fluids
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462675A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
04/10/2003CA2462594A1 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
04/10/2003CA2462414A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
04/10/2003CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
04/09/2003EP1300404A1 Obesity inhibitory materials
04/09/2003EP1300403A1 Process for the manufacture of hypoxyxylerone derivatives
04/09/2003EP1300138A2 Agents effective against hyperreactive and hypoactive deficient skin conditions as well as manifest dermatitis
04/09/2003EP1299413A2 Homogentisate phytyl transferase
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
04/09/2003EP1299342A1 Method for producing 3,3-diarylpropylamines